[Therapy in kidney transplant rejection using murine monoclonal IgG2a A1CD3 (Cedetrin)].

J Jirka,P Rossmann, J Tĕsínská,I Reneltová, F Saudek,J Kaslíková, J Gintelová,I Matl,J Kaslík

Casopis lekaru ceskych（1994）

引用 23|浏览3

暂无评分

摘要

The therapeutic administration of monoclonal mouse globulin IgG2a A1CD3 (Cedetrin), developed in the Institute of Molecular Genetics, Academy of Sciences, Czech Republic, produced by Exbio Co., CR) has a favourable effect on rejection episodes or progressing rejection of transplanted kidneys. Treatment is indicated in confirmed histologically active rejection.

查看译文

关键词

kidney transplant rejection,cedetrin,murine monoclonal

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要